Sai Life Sciences has emerged as one of the fastest-growing contract research, development, and manufacturing organizations (CRDMOs). It is among the few CRDMOs with research facilities strategically located near global innovation hubs, including Watertown (Greater Boston, MA) in the United States and Manchester in the United Kingdom. These are complemented by large-scale research and manufacturing centers in cost-effective regions across India.

The company has collaborated with over 280 innovative pharmaceutical firms, including 18 of the top 25 pharma companies, serving highly regulated markets such as the US, UK, Europe, and Japan. Additionally, Sai Life Sciences provides ongoing contract research organization (CRO) support to more than 60 clients for integrated drug discovery programs. By 30 September 2024, its CDMO portfolio featured over 170 pharmaceutical products, with 38 contributing to the production of 28 commercial drugs.

Globally, the company employs 3,135 professionals, of which 2,353 are scientific staff. This includes a highly skilled team of 302 PhDs and 1,475 master’s degree holders, showcasing its strong focus on advanced scientific expertise